Securities code: 300529 securities abbreviation: Jafron Biomedical Co.Ltd(300529) Announcement No.: 2022-004 bond Code: 123117 bond abbreviation: Jianfan convertible bond
Jafron Biomedical Co.Ltd(300529)
Announcement on increasing registered capital, changing business scope and amending the articles of Association
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
On January 17, 2022, Jafron Biomedical Co.Ltd(300529) (hereinafter referred to as “the company”) convened the 29th meeting of the Fourth Board of directors, deliberated and adopted the proposal on increasing registered capital, changing business scope and amending the articles of association. In view of:
1、 The incentive objects of the company’s stock option incentive plan independently exercised 31863 options from July 1, 2021 to September 30, 2021, increasing the total share capital of the company by 31863 shares. In addition, on August 23, 2021, the company completed the registration of the suspended part of class I restricted shares of the company’s 2021 restricted stock incentive plan, increasing the total share capital of the company by 160000 shares. To sum up, the total share capital of the company has increased from 805018708 to 805497338, and the registered capital of the company will correspondingly increase from 805018708 to 805497338.
2、 According to the company’s development plan and actual production and operation needs, the company plans to add “pre packaged food sales” to the original business scope. At the same time, according to the requirements for the standardized expression of business scope in the Circular of Zhuhai market supervision and administration on the implementation of the standardized expression of business scope, the company plans to revise the business scope in the articles of association. The revised business scope is:
Licensed items: production of class III medical devices; Class III medical device business; Class III medical device leasing; Production of class II medical devices; Food sales; The second category of value-added telecommunications services; Medical device Internet information service; Drug Internet information service; Wholesale of drugs; Drug retail; Import and export of drugs; Medical services; Road cargo transportation (excluding dangerous goods); Inspection and testing services. (for projects that must be approved according to law, business activities can be carried out only with the approval of relevant departments. The specific business projects shall be subject to the approval documents or licenses of relevant departments)
General items: Sales of class II medical devices; Class II medical device leasing; Production of class I medical devices; Sales of class I medical devices; Class I medical device leasing; Sales of food additives; Medical research and experimental development; Engineering and technical research and test development; Sales of synthetic materials; Sales of engineering plastics and synthetic resin; Sales of packaging materials and products; Research and development of bio based materials technology; Sales of bio based materials; Sales of new membrane materials; Sales of plastic products; Sales of high-performance fibers and composites; Sales of chemical products (excluding licensed chemical products); Sales of special chemical products (excluding hazardous chemicals); Sales of disinfectants (excluding hazardous chemicals); Repair of special equipment; Manufacturing of special equipment (excluding manufacturing of licensed professional equipment); Sales of mechanical equipment; Sales of wearable smart devices; Research and development of Internet of things technology; Internet of things equipment manufacturing; Internet of things equipment sales; Internet of things technical services; Internet of things application services; Network and information security software development; Software development; Software sales; Software outsourcing services; Manufacturing of computer software, hardware and peripheral equipment; Computer and office equipment maintenance; Information system integration service; Data processing and storage support services; Information system operation and maintenance services; Information technology consulting services; Internet data services; Big data service; Health consulting services (excluding diagnosis and treatment services); Remote health management services; Sales of daily necessities; Sales of daily necessities; Technical services, technical development, technical consultation, technical exchange, technology transfer and technology promotion; Information consulting services; Import and export of goods; Technology import and export; China trade agency; Intellectual property services (except patent agency services); General cargo warehousing services (excluding hazardous chemicals and other items requiring license and approval); Housing lease; Non residential real estate leasing; Leasing services (excluding licensed leasing services). (except for the items that must be approved according to law, the company shall independently carry out business activities according to law with its business license)
(the above details shall be subject to the industrial and commercial approval and registration)
3、 To sum up, it is proposed to amend the articles of association. The specific amendments are as follows:
Before and after modification
Article 6 the registered capital of the company is RMB 800 million. Article 6 the registered capital of the company is RMB 800 million, five million eighteen thousand seven hundred and eight, five million four hundred and ninety-seven thousand three hundred and thirty-eight (￥ 805018708), and the paid in capital is (￥ 8054973380), The paid in capital is RMB eight hundred and five million eighteen thousand seven hundred and eighty-five million four hundred and ninety-seven thousand three hundred and eight (RMB 805018708). Three hundred and eighty yuan (￥ 8054973380).
Article 13 after registration according to law, the business scope of the company shall include: medical devices, instruments and equipment and their business scope shall include:
License items of spare parts and software products related to products: production of class III medical devices; R & D, manufacturing, sales and technical consulting and services; Class III medical device business; Leasing of class III medical devices and drugs, formula food for special medical purposes and special equipment; Production of class II medical devices; Sales of food, health food, health products and medical products; The second category of value-added telecommunications services; Packaging materials for medical devices, disinfectants, biological culture media, machinery and Internet information services; Drug Internet information biological products, biological reagents and chemical reagents (no service); drug wholesale; drug retail; Drug Import
Including hazardous chemicals), sanitary materials and medical exports; Medical services; Road cargo transportation (excluding dangerous goods, biological materials, medical polymer materials, especially dangerous goods); Inspection and testing services. (for projects subject to approval according to composite materials and products, fine chemical materials and laws, washing supplies, batteries and chemical products (business activities can be carried out only after they are not included, and specific business items are toxic, harmful, flammable, explosive and dangerous chemicals) shall be approved by relevant departments, and the R & D, manufacturing, sales and technology of relevant products shall be subject to the approval documents or licenses of relevant departments)
Consulting and services; General items of medical computer software products: Sales of class II medical devices; Development, sales and system management and maintenance (leasing of class II medical devices by law; no operation of class I medical devices prohibited by laws and regulations and decisions of the State Council; production of medical devices; sales of class I medical devices; leasing of class I medical devices subject to approval by relevant departments for projects subject to approval by law; sales of food additives; business activities can be carried out only after approval); Medical science and technology, medical research and experimental development; Engineering and technology research, technology research and experimental development in the fields of information technology and Biotechnology; Sales of synthetic materials; Engineering development, technology transfer, technology promotion services, technical plastics and synthetic resin sales; Packaging materials and manufacturing consulting; Concurrently engaged in medical services, sales of self owned houses and leased goods; Research and development of bio based materials technology; Biological and sales, mechanical equipment leasing, general freight; Sales of base materials; Sales of new membrane materials; Import and export business of plastic goods and technologies (excluding national product sales; sales of prohibited and restricted goods and technologies of high-performance fibers and composites).
Sale; Sales of chemical products (excluding activities within the business scope of licensed chemical companies. Products according to the law); Sales of special chemical products (excluding hazardous chemicals that must be licensed according to hazardous laws, regulations and decisions of the State Council); Disinfectant sales (excluding hazardous items, chemicals shall be sold after applying to the relevant licensing department); Repair of special equipment; Special equipment shall be operated on the strength of license examination and approval documents or license certificates. Manufacturing (excluding licensed professional equipment manufacturing); The business scope of the company shall be the sale of mechanical equipment in Zhuhai according to regulations; Sales of wearable smart devices; Business entity registration license and credit publicity platform to Internet of things technology research and development; Internet of things equipment manufacturing; By publicity. Internet of things equipment sales; Internet of things technical services; Internet of things application services; Network and information security software development; Software development; Software sales; Software outsourcing services; Manufacturing of computer software, hardware and peripheral equipment; Computer and office equipment maintenance; Information system integration service; Data processing and storage support services; Information system operation and maintenance services; Information technology consulting services; Internet data services; Big data service; Health consulting services (excluding diagnosis and treatment services); Remote health management services; Sales of daily necessities; Sales of daily necessities; Technical services, technical development, technical consultation, technical exchange, technology transfer and technology promotion; Information consulting services; Import and export of goods; Technology import and export; China trade agency; Intellectual property services (except patent agency services); General cargo warehousing services (excluding hazardous chemicals and other items requiring license and approval); Housing lease; Non residential real estate leasing; Leasing services (excluding licensed leasing services). (except for the items that must be approved according to law, the company shall independently carry out business activities according to law with its business license)
Article 19 the total number of shares of the company is 805 million Article 19 the total number of shares of the company is 805 million eighteen thousand seven hundred and eight shares, four hundred and ninety-seven thousand three hundred and thirty-eight shares (805018708 shares), and the share capital of the company is 8054973380 shares, The share capital structure of the company is: eight hundred and five million eighteen thousand ordinary shares, consisting of eight hundred and five million four hundred and ninety seven hundred and eight ordinary shares (805018708 shares), thirteen hundred and thirty-eight shares (805497338 shares) and zero (0) shares of other types. Zero (0) shares of other classes.
Except for the above amendments, other provisions remain unchanged.
This matter needs to be approved by the general meeting of shareholders.
It is hereby announced.
Jafron Biomedical Co.Ltd(300529) board of directors January 17, 2022
